Revive Therapeutics Engages Novotech as Asia-Pacific CRO for Bucillamine in the Treatment of Infectious Diseases

NEXT STORY
Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens
PREV STORY
Former US Ambassador and Assistant Director-General of the World Health Organization on HIV/AIDS, Tuberculosis and Malaria Dr. Jack C. Chow Joins Draganfly Board of Advisors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

King Edward VII’s Hospital Selects Vital Images’ Modular Enterprise Imaging Solution

LONDON, Oct. 19, 2016 (GLOBE NEWSWIRE) -- King Edward VII’s Hospital, London’s foremost private ...

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Provides Development Update on Brilacidin for Inflammatory Bowel Disease

BEVERLY, Mass., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc. (OTCQB:IPIX) (“the Company”), ...

author_avatar
NASDAQ Market News

Athenex, Inc. Announces Approval of Tax Incentives from State of New York for the Dunkirk Facility

BUFFALO, N.Y., July 27, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

author_avatar
NASDAQ Market News